PRESCRIBING · PART D · 2024
Total Rx claims
345
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
13
Brand share
21.2%
Top prescribed drugs
Levetiracetam89 claims
Ondansetron Hcl36 claims
Lamotrigine35 claims
Memantine Hcl28 claims
Ivosidenib27 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE